Compound 1 exhibited potent activity against N-myristoyltransferase (NMT), a promising drug target for human African trypanosomiasis (HAT) caused by the parasitic protozoa Trypanosoma brucei. The gene discussed is NMT1; the disease is human African trypanosomiasis.